Cite
HARVARD Citation
Lin, J. et al. (2016). A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone. Oncologist. pp. 1296-1297e. [Online].